Translational Pain Research: Comparing preclinical studies and clinical pain management. Lost in translation?Basic science and clinical pain research is particularly challenging for several reasons. First, pain is a subjective experience in response to nociception that follows actual or potential tissue damage. Since the ability to respond to this warning signal is essential for our survival, the nociceptive system that produces and transmits nociceptive signals is remarkably redundant and involves diffuse regions of the central nervous system. Second, unlike other sensory modalities, pain is a multi-dimensional experience including at least cognitive, affective, and sensory-discriminative components. Third, pain experiences can be influenced by psychological, socioeconomic, cultural, and genetic predispositions, making it exceedingly complicated to study pain and pain modulation. The topics covered in this volume are carefully selected and directly related to the daily practice of pain medicine. These topics include 1) central mechanisms of pain and pain modulation (Dickenson, Donovan-Rodriguez, Mattews) and clinical use of ion channel blockers (Chen); 2) spinal glutamatergic mechanisms (Guo, Dubner, Ren) and issues related to glutamate receptor antagonists in pain management (Mao); 3) basic science of opioid analgesics (Gintzler, Chakrabarti) and clinical opioid use (Smith, McCleane); 4) inflammatory cytokines (Samad) and clinical use of anti-inflammatory drugs (Fink, Brenner); 5) role of the sympathetic nervous system in pain mechanisms and its relation to clinical pain management (Sharma, Raja); 6) preclinical studies on tricyclic antidepressants (Gerner, Wang) and clinical use of antidepressants in pain management (Greenberg); 7) developing pain pathways and analgesic mechanisms during the developmental stage (Fitzgerald) and challenges of pediatric pain management (Lebel); 8) basic science mechanisms of serotonin agonists and their use in the clinical management of migraine headache (Biondi); 9) clinical research on gender differences in clinical pain and their implications for clinical pain management (Holdcroft); 10) current modalities of clinical cancer pain management (Popescu, Hord); and 11) preclinical and clinical information on alternative medicine (Chen). |
Contents
23 | |
Spinal NMethylDAspartate Receptor Mechanisms of Central Sensitization and Persistent Pain Following Tissue Injury | 43 |
NMDA Receptor Antagonists and Clinical Pain Management | 77 |
Plasticity of Signaling Molecules and Their Associations after Chronic Morphine Altered but Not Lost Opioid ReceptorCoupled Functionality | 85 |
Opioids for Pain Management | 107 |
Inflammatory Mediators in the Mechanisms of Nociception Preclinical Studies | 145 |
Antiinflammatory Medications in Pain Management | 153 |
Antidepressant Medication in Clinical Pain Management | 205 |
Developing Pain Pathways and Analgesic Mechanisms Towards Translational Studies | 219 |
Pediatric Pain Management In Translation | 237 |
Selective Serotonin Agonists for the Acute Management of Migraine | 251 |
Gender Differences in Clinical Pain Management | 275 |
Clinical Management of Cancer Pain | 293 |
Complementary and Alternative Medicine in Pain Management | 315 |
Index | 329 |
Chronic Pain and the Sympathetic Nervous System Mechanisms and Potential Implications for Pain Therapies | 167 |
Mechanisms of Tricyclic Antidepressants in Pain Modulation | 187 |
Common terms and phrases
activity acupuncture acute agonists allodynia amitriptyline analgesia analgesic analgesic effects anesthetic antidepressants back pain behavior block bone Brain Res cancer pain cells central sensitization channel blockers chronic morphine chronic pain CIBP Clin clinical pain management clinical trials clinicians controlled trial dorsal horn dorsal horn neurons dose drug efficacy fentanyl function G protein gabapentin gender headache human hyperalgesia increased induced inflammation inflammatory inhibition inhibitors injection intrathecal intravenous lidocaine LTOT major depressive disorder mechanisms mediated migraine migraine attacks modulation morphine neonatal nervous system neuralgia neurons neuropathic pain Neurosci NMDA receptor antagonists nociceptive nociceptors noncancer pain NR2B NSAIDs opioid receptor opioid therapy opioid tolerance oral oxycodone pain conditions pain relief pathways patients peripheral Pharmacol pharmacological phosphorylation placebo potential preclinical protein kinase receptive fields release response role sensory serotonin side effects signaling sodium channel spinal cord stimulation studies subunit sumatriptan sympathetic symptoms TCAs therapeutic treatment triptans tyrosine phosphorylation
Popular passages
Page 17 - Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Page 14 - Akopian, AN, Souslova, V., England, S., Okuse, K., Ogata, N., Ure, J., Smith, A., Kerr, BJ, McMahon, SB, Boyce, S., Hill, R., Stanfa, LC, Dickenson, AH and Wood, JN (1999) The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways.